Wearable device tracks walking patterns to spot dementia risk

NCT ID NCT07127133

Not yet recruiting Diagnosis Sponsor: HealthPartners Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable insole and ankle device that measures walking patterns to detect early cognitive decline in older adults. Researchers will collect gait data from 150 participants—some healthy, some with mild cognitive impairment or dementia—first in a lab and then during a week of everyday use at home. The goal is to see if the device can accurately identify people at risk for Alzheimer's disease or related dementias.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: wearable insole and ankle device
What this could lead to: If successful, this could provide a simple, at-home way to detect early cognitive decline, potentially leading to earlier diagnosis and monitoring of Alzheimer's disease.
What could go wrong: This is an early-stage study with only 150 participants, focused on measuring gait accuracy, not on treatment. The device may not reliably distinguish cognitive decline from normal aging or other conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEMENTIA MILD COGNITIVE IMPAIRMENT (MCI)

Contacts and locations

Locations

HealthPartners Neuroscience Center

Saint Paul, Minnesota, 55130, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.